Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

335 total articles

ASML: Buy the Advanced Node Monopoly with a Measured Long Trade

ASML: Buy the Advanced Node Monopoly with a Measured Long Trade

ASML's monopoly on EUV lithography is powering another leg of compounding: record Q4 orders (€13.2bn), 2026 guidance raised to €34-39bn and a €12bn buyback underpin growth and capital returns. Technicals show bullish momentum, but a steep valuation (PE ~51, PB ~24.7) and China exposure create near-term jolt risk. Trade plan: go long at $1426.74, ta…

Booking Holdings Pullback: A Tactical Buy Around $5,000

Booking Holdings Pullback: A Tactical Buy Around $5,000

Booking Holdings (BKNG) has drifted off recent highs and is trading below several moving averages with an RSI under 40. Fundamentals remain solid: high free cash flow, profitable operations and a market cap near $162B. For traders, a disciplined entry near $5,000 with a $4,850 stop and a $5,600 target offers asymmetric risk-reward over the next 45 …

Parex Rebound - Momentum Meets a Crowded Short: A Tactical Long

Parex Rebound - Momentum Meets a Crowded Short: A Tactical Long

Parex Resources (PARXF) has threaded a series of higher moving averages, a bullish MACD and a rising RSI while short interest remains extremely high. This trade idea targets a momentum-driven rally into the mid-$17s with a defined stop under the 50-day moving average. High short interest means volatility can work for or against you - position sizin…

Insmed: Don't Let Brensocatib Noise Obscure a BRINSUPRI Adoption Story

Insmed: Don't Let Brensocatib Noise Obscure a BRINSUPRI Adoption Story

Insmed shares have been knocked around by negative headlines on the development side, but the company already has a commercially approved DPP1 inhibitor, BRINSUPRI, with consensus peak sales potential near $5 billion. With a market cap of roughly $33.5 billion and supportive technicals, this trade idea buys the pullback into what we view as an othe…

ServiceNow: Positioning to Become the Enterprise AI Workflow Backbone

ServiceNow: Positioning to Become the Enterprise AI Workflow Backbone

ServiceNow's Now Platform is increasingly central to enterprise automation and AI-driven workflows. Q4 results show $3.57B revenue and 21% YoY growth, while balance sheet strength and $4.58B free cash flow give the company runway to integrate recent AI-focused acquisitions. The stock is materially oversold (RSI ~25) and trading near its 52-week low…

Intel's 18A Inflection: A Tactical Long on Foundry Repricing

Intel's 18A Inflection: A Tactical Long on Foundry Repricing

Intel's heavy hardware bet - high-NA EUV, 14A/18A node roadmaps and a potential Apple foundry relationship - creates a measurable trade setup. The company is priced for turnaround but not for a successful execution of its foundry and data center AI growth. This trade idea buys the gap between current skepticism and a plausible operational pickup ov…

AMD vs Intel: Why AMD Is Set to Pull Ahead in 2026 and How to Trade It

AMD vs Intel: Why AMD Is Set to Pull Ahead in 2026 and How to Trade It

AMD looks positioned to widen its lead over Intel in 2026 as hyperscalers diversify AI infrastructure away from a single-vendor GPU market. The balance sheet is healthy, cash generation is solid, and technicals show constructive momentum. This trade idea lays out an entry at $237.00, a stop at $200.00 and a primary target of $375.00 over a 180 trad…

Millicom (TIGO) — Turnaround Complete; Time for a Cash-Flow Reprice

Millicom (TIGO) — Turnaround Complete; Time for a Cash-Flow Reprice

Millicom has finished the heavy lifting: consolidation in Colombia, targeted M&A in Ecuador, and infrastructure monetizations have materially improved cash flow visibility. At a market cap near $10.2B, a sub-4x run-rate EV/EBITDA implied valuation, a 4.9% yield and single-digit P/E, TIGO looks positioned for a cash-flow rerating. This trade idea la…

Ibtrozi Rollout Momentum Makes Nuvation Bio a Modest Buy

Ibtrozi Rollout Momentum Makes Nuvation Bio a Modest Buy

Nuvation Bio (NUVB) has traded off sharply since its 52-week high, but supportive rollout commentary on Ibtrozi, a solid cash position and a beaten-down technical set create an asymmetric risk/reward for a measured long. This trade idea lays out entry, stop and target with horizon and risk framing.

AMD as Nvidia’s Practical Partner: A Swing Trade Ahead of Q4

AMD as Nvidia’s Practical Partner: A Swing Trade Ahead of Q4

AMD has moved from niche contender to essential infrastructure partner for hyperscalers that are building out AI datacenters. With a $385B market cap, improving data center traction, positive technical momentum, and attractive free cash flow generation, AMD is a high-conviction swing trade ahead of the quarter-end print. Entry, stop, and target are…

Ciena at the Center of AI Bandwidth - A Tactical Long with Defined Risk

Ciena at the Center of AI Bandwidth - A Tactical Long with Defined Risk

Ciena is benefiting from a second wave of AI infrastructure spending as hyperscalers and cloud providers expand high-capacity optical links inside and between data centers. Strong orders and a growing backlog have driven an outsized stock move, but valuation is rich. This trade idea favors a disciplined long with entry at $252.00, a $320.00 target …

Buy on the Dip: A March Regulatory Decision Could Re-Rate Protalix (PLX)

Buy on the Dip: A March Regulatory Decision Could Re-Rate Protalix (PLX)

Protalix (PLX) is a small-cap biotech with a near-term March decision risk/reward. The company trades at roughly $187M market cap, has no debt, and carries enough cash to fund operations near-term. If the March regulatory outcome is positive, shares can re-test prior highs quickly; if negative, downside is clear. This trade idea lays out an entry a…

USA Rare Earth: Play the Policy Volatility - A Mid-Term Long Swing

USA Rare Earth: Play the Policy Volatility - A Mid-Term Long Swing

USA Rare Earth just got a headline-making financing package from Washington that materially reduces bankruptcy risk and funds an aggressive build-out. That same government relationship is the source of rapid sentiment swings after reports the administration may scale back price-floor support. For nimble traders, there is a defined mid-term long tra…